- AU$7.89m
- AU$3.87m
- AU$0.18m
Australia Stock Exchange release from INVEX THER : PRE_NR Ends: 08:14:03
Invex Therapeutics sees best day in 6 months on European patent grant
Australia Stock Exchange release from INVEX THER : Invex Granted Key European Patent for Exenatide
Australia Stock Exchange release from INVEX THER : PRE_NR Ends: 11:31:43
Australia Stock Exchange release from INVEX THER : Appendix 2A
Australia Stock Exchange release from INVEX THER : Notice of Upcoming Release of Securities from Escrow
Australia Stock Exchange release from INVEX THER : Investor Presentation
Australia's Invex hits record low on U.S. FDA response on clinical trial plan
Brief: Invex Therapeutics Receives Written Response From FDA On Type C Meeting
Australia Stock Exchange release from INVEX THER : Formulation and Manufacturing Update
Australia Stock Exchange release from INVEX THER : Invex Granted Type C Meeting with FDA
Australia Stock Exchange release from INVEX THER : PRE_NR Ends: 09:40:58
Australia Stock Exchange release from INVEX THER : Appendix 4C - quarterly
Australia Stock Exchange release from INVEX THER : PRE_NR Ends: 09:26:35
Australia Stock Exchange release from INVEX THER : Appendix 3G
Australia Stock Exchange release from INVEX THER : Change of Director's Interest Notice
Australia Stock Exchange release from INVEX THER : Results of Meeting
Australia Stock Exchange release from INVEX THER : Chairman's Address to Shareholders
Brief: Invex Therapeutics Files Pre-Ind/Type B Meeting Request With US FDA